Methylene Blue

Methylene blue functions as a redox cycling agent in mitochondria. In its oxidized form, it accepts electrons from NADH through Complex I and is reduced to leucomethylene blue. The reduced form then donates these electrons directly to cytochrome c, which passes them to Complex IV (cytochrome c oxidase), the terminal enzyme in the electron transport chain. This creates an alternative electron transfer pathway that can bypass dysfunctional Complex I and Complex III, maintaining the proton gradient across the inner mitochondrial membrane and sustaining ATP synthesis even under conditions of mitochondrial stress or inhibition. Additionally, by diverting electron flow away from sites of superoxide generation at Complex I and Complex III, methylene blue reduces mitochondrial production of reactive oxygen species. Methylene blue also inhibits monoamine oxidase A (MAO-A), which slows the degradation of serotonin, norepinephrine, and dopamine, contributing to its mood and cognitive effects. It inhibits nitric oxide synthase (NOS) and guanylate cyclase, which can affect vascular tone and neuroinflammation. At higher concentrations, methylene blue exhibits pro-oxidant behavior rather than antioxidant, which is why therapeutic benefit follows a hormetic dose-response curve where low doses enhance function and high doses become counterproductive.